Size and SUVmax define the contribution of nodal metastases to PSA in oligorecurrent prostate cancer

Documenti analoghi

• Bimodal imaging: Detection rate of clinically significant prostate cancer is higher in MRI lesions visible to transrectal ultrasound
  di: Fabian Falkenbach, et al.
  Pubblicazione: (2024)
• Reply – Letter to the Editor: Bimodal Imaging at MRI Fusion Prostate Biopsy Will Gain Further Importance in the Future
  di: Fabian Falkenbach, et al.
  Pubblicazione: (2025)
• USPSTF Recommendation Against PSA Screening vs. Stage and Cancer‐Specific Mortality in Localized Prostate Cancer
  di: Fabian Falkenbach, et al.
  Pubblicazione: (2025)
• Serum levels of prostate specific antigen, free PSA, [−2]proPSA, fPSA/tPSA ratio, Prostate Health Index, and glycosylation patterns of free PSA in patients with benign prostatic hyperplasia pharmacotherapy
  di: Michal Jirásko, et al.
  Pubblicazione: (2024)
• Prognostic value of circulating tumor cells in oligorecurrent hormone‐sensitive prostate cancer patients undergoing stereotactic body radiation therapy
  di: Fabio Matrone, et al.
  Pubblicazione: (2024)